Intrinsic Value of S&P & Nasdaq Contact Us

SiriusPoint Ltd. SPNT NYSE

NYSE • Financial Services • Insurance - Reinsurance • BM • USD

SharesGrow Score
75/100
4/7 Pass
SharesGrow Intrinsic Value
$24.79
+10%
Analyst Price Target
$25.00
+10.9%

SiriusPoint Ltd. (SPNT) is a Insurance - Reinsurance company in the Financial Services sector, currently trading at $22.54. It has a SharesGrow Score of 75/100, indicating a strong investment profile with 4 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of SPNT = $24.79 (+10% from the current price, the stock appears fairly valued). Analyst consensus target is SPNT = $25 (+10.9% upside).

Valuation: SPNT trades at a trailing Price-to-Earnings (P/E) of 5.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.74.

Financials: revenue is $3.2B, +1355.2%/yr average growth. Net income is $460M, growing at +92.7%/yr. Net profit margin is 14.3% (healthy). Gross margin is 52.6% (-47.4 pp trend).

Balance sheet: total debt is $689M against $2.5B equity (Debt-to-Equity (D/E) ratio 0.28, conservative). Debt-to-assets is 568.2%. Total assets: $121M.

SharesGrow 7-Criteria breakdown: Value 90/100 (Pass), Growth 100/100 (Pass), Past 75/100 (Partial), Health 75/100 (Pass), Moat 59/100 (Partial), Future 70/100 (Pass), Income 55/100 (Partial).

SPNT SharesGrow Score Overview

75/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 90/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 75/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 59/100
Gross margin is + market cap
FUTURE 70/100
Analyst outlook — as buy
INCOME 55/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SPNT

VALUE Pass
90/100
SPNT trades at a trailing Price-to-Earnings (P/E) of 5.9 (S&P 500 average ~25). Forward PEG 0.74 — Peter Lynch undervalued (≤1.0). Trailing PEG 0.04. Analyst consensus target is $25, implying +10.9% from the current price $23. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
SPNT: +1355.2%/yr revenue is, +92.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
SPNT: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
75/100
Balance sheet SPNT: Debt-to-Equity (D/E) ratio 0.28 (conservative), Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
59/100
SPNT: Gross margin is 52.6% (-47.4 pp trend), $3B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 59/100. ≥ 70 = Pass.
View details →
FUTURE Pass
70/100
Analyst outlook: 0 / 0 analysts rate SPNT as buy. Analyst consensus target is $25 (+10.9% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
55/100
SPNT: Net profit margin is 14.3%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range14.76-22.89
Volume445.94K
Avg Volume (30D)783.09K
Market Cap$2.64B
Beta (1Y)0.65
Share Statistics
EPS (TTM)3.81
Shares Outstanding$116.51M
IPO Date2013-08-15
Employees1,012
CEOScott Egan
Financial Highlights & Ratios
Revenue (TTM)$3.21B
Gross Profit$1.69B
EBITDA$622.5M
Net Income$459.6M
Operating Income$541.3M
Total Cash$902.4M
Total Debt$688.6M
Net Debt$-213.8M
Total Assets$121.2M
Price / Earnings (P/E)5.9
Price / Sales (P/S)0.82
Analyst Forecast
1Y Price Target$25.00
Target High$25.00
Target Low$25.00
Upside+10.9%
Price Target Summary
Company Info
CountryBM
ExchangeNYSE
CurrencyUSD
ISINBMG8192H1060

Price Chart

SPNT
SiriusPoint Ltd.  ·  NYSE
Financial Services • Insurance - Reinsurance
14.76 52WK RANGE 22.89
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message